Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi Pasteur, a Sanofi Company
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Aged ≥ 42 days and ≤ 89 days on the day of inclusion
Born at full term of pregnancy (≥ 36 weeks)
Informed consent form signed by the parent(s) or other legally authorized representative(s) before the 1st study related procedure
Vaccination with a hepatitis B vaccine at least 30 days before inclusion
Able to attend all scheduled visits and to comply with all trial procedures(i.e., access to a phone)
Provide blood sample prior to Dose 1
Parent or legal representative willing to take rectal temperatures after each vaccination.
You may not be if
Participation in another clinical trial in the 4 weeks preceding the (first)trial vaccination
Planned participation in another clinical trial during the present trial period
Personal or immediate family history of congenital or acquired immunodeficiency, immunosuppressive therapy such as long-term systemic corticosteroids therapy
Known or suspected systemic hypersensitivity to any of the vaccine components or history of a life-threatening reaction to a vaccine containing the same substances as the trial vaccine(s)
Chronic illness that could interfere with trial conduct or completion
Received blood or blood-derived products since birth
Any vaccination in the 2 weeks preceding the first trial vaccination or planned in the 4 weeks after any trial vaccination. Flu vaccine could be administered only 2 weeks after any trial vaccination
Previous vaccination with any acellular pertussis- (DTaP) or whole cell pertussis- (DTwP) based combination vaccines, Haemophilus influenzae type b (Hib)-conjugate, poliovirus, or pneumococcal conjugate vaccines
